Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001851005 | SCV002185576 | uncertain significance | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-11-02 | criteria provided, single submitter | clinical testing | This variant, c.2607_2609del, results in the deletion of 1 amino acid(s) of the SETX protein (p.Lys870del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs781159054, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with SETX-related conditions. ClinVar contains an entry for this variant (Variation ID: 373903). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003322767 | SCV004028211 | uncertain significance | not provided | 2023-02-15 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of one amino acid in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Centre for Mendelian Genomics, |
RCV000414828 | SCV000492529 | uncertain significance | Dystonic disorder; Mental deterioration | 2016-08-22 | no assertion criteria provided | clinical testing |